What is PhenProcoumon?
Fenprocoumon is closely related to warfarin and is an anticoagulant drug used for thin thinning of blood or stop it in clotting. It is derived from Coumarin and works by blocking the effect of vitamin K, which is an essential component in the body of the body clotting. In some countries of the world there are a number of different drugs containing PhenProcoumon. According to the manufacturer, they are known under various trade names.
The body's coagulation cascade is complex and includes many proteins and chemicals. Vitamin K plays an essential role in the formation of various coagulation factors that are necessary for coagulation. Fenprocoumon acts as an antagonist of vitamin K; This means that it stops the effect of vitamin K, thus preventing the formation of these colliding factors and preventing coagulation. In most countries, prescription is only available and requires careful titration to achieve the idea of an anticoagulant dose. This may vary significantly from person to man and require careful monitoring, especially initially, but also during therapy.
BA may be prescribed to a patient who had a clot, either a deep thrombosis vein (DVT) or pulmonary thrombosis, after myocardial infarction or heart attack, as well as to prevent patients with atrial fibrile. The dose and duration may vary according to the clinical indication and the patient's reaction. The prescribed dose should never be exceeded.
Many drugs can affect phenocumone levels and lead to blood too strong or too thin. Any parallel drugs, including complementary therapies, homeopathic drugs and over -the -counter medicines, should be discussed with your doctor. The change in dose or interruption of the drug may also affect PhenProcoumon and the patient's person should be monitored. Some medicines such as drugs that can also cause anticoagulation are contraindicated in combination with Fenprocoumon.
As with any medicine, PhenProcoumon mayObit adverse effects. Hepatotoxicity, bleeding and bone loss after chronic use were reported. If any side effect was experienced, immediate medical care should be sought. Pregnancy, required pregnancy and lactation should be discussed with a prescribing physician before considering the start of therapy. When overdose, PhenProcoumon may be fatal, so they must be detained out of the reach of children.
The duration of phenocumone treatment depends on the treated condition and its severity. In some cases, anticoagulant therapy is lifelong, while in others therapy may be stopped after several months. Treatment should never be stopped without looking for medical advice first.